SPYPBO-102, SPYPBO-101, SPY002, SPY002, SPY001-001, SPY001-001
SPY123-201
Phase 2 small_molecule active
Quick answer
SPYPBO-102, SPYPBO-101, SPY002, SPY002, SPY001-001, SPY001-001 for Moderately to Severely Active Ulcerative Colitis is a Phase 2 program (small_molecule) at Spyre Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Spyre Therapeutics
- Indication
- Moderately to Severely Active Ulcerative Colitis
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active